See the Biology of Sepsis –
for the First Time

Learn More:

IntelliSep Offers Early Sepsis Detection with Clear, Actionable Results

IntelliSep is a diagnostic tool that risk- stratifies patients based on their probability of having sepsis within the following 3 days post-testing. IntelliSep provides results in around 8 minutes, enabling faster care and optimized patient outcomes.

IntelliSep is an FDA-cleared in vitro diagnostic test for adult patients with signs and symptoms of infection who present to the Emergency Department

All results should be interpreted in the context of the other clinical observations and laboratory test results for the patient

IntelliSep offers a highly sensitive measure for identifying sepsis by analyzing the immune response to infection through the biomechanical properties of white blood cells. 

Unlike Other Time-Sensitive Medical Emergencies, Sepsis Lacked a Highly Sensitive Detection Tool.

Until Now.

Sepsis is a medical emergency requiring rapid diagnosis and treatment, with an 8% increase in mortality for every hour that treatment is delayed.1

Like heart attack and stroke, now there is an objective detection tool for sepsis.

  1. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension prior to initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589-1596.

Today’s Understanding of Sepsis Requires An Innovative Approach

IntelliSep assesses immune activation, and provides a probability of sepsis occurring within 3 days of testing

Source: Graphic adapted from Mervyn Singer, MD, European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2022.

Today’s Understanding of Sepsis Requires An Innovative Approach

IntelliSep assesses immune activation and provides a probability of sepsis occurring within 3 days of testing.

Infection is common and most of the time it leads to a regulated immune response, and is self limiting.

However, some infections lead to dysregulated immune response, causing life threatening organ failure. This is sepsis and can lead to long-term morbidity and mortality.

Early diagnosis is key to providing appropriate treatment and achieving source control, leading to better outcomes.

Historically it has been difficult to identify the state of immune activation in real-time, to see who is septic.

Now, with IntelliSep you can, leading to early sepsis detection and the best outcomes.

Why IntelliSep?

IntelliSep enables Emergency Department providers to cut through clinical uncertainty by risk-stratifying patients with signs and symptoms of infection, and identifying those experiencing the medical emergency of sepsis.

The Power of Seeing Immune Activation

  • Receive IntelliSep results alongside other STAT tests
  • Triage patients faster to the appropriate care pathway
  • Shorten length of stay1
  • Improve ED throughput with rapid sepsis test results
  • Prioritize ED resources effectively based on sepsis risk
  • Reduce costs by minimizing inappropriate care and shortening length of stay1 
  • Reduce overhead sepsis alerts using IntelliSep and enhanced sepsis protocols1
  • Improve diagnostic confidence with test results you can trust1
  • Deliver patient-centered care informed using timely, accurate test results1

Learn more about how IntelliSep can help your team.

1. The above represents one site’s experience with IntelliSep.

Cytovale in the News